The identification of novel pan-sigma receptor (SR) modulators, potentially useful in cancer treatment, represents a new goal of our research. Here, we report on the preparation of novel chiral compounds characterized by a 3-C alkyl chain bridging an aromatic portion to a 4-benzyl-piperidine moiety. All of the studied compounds have been prepared both in racemic and enantiomerically-pure form, with the final aim to address the role of chirality in the SR interaction. To isolate and characterize enantiomeric compounds, high-performance liquid chromatography (HPLC) procedures were set up. A systematic analytical screening, involving several combinations of chiral stationary and mobile phases, allowed us to optimize the analytical resolution a...
A direct HPLC enantioseparation of three representative compounds of a new family of potential non-p...
The enantiomers of four chiral 3-aryl-substituted-\u3b3-butyrolactones, key intermediates for the pr...
The enantiomers of cis-(+/-)-methyl (1R,2S/1S,2R)-2-[(4-hydroxy-4-phenylpiperidin-1-yl)methyl]-1-(4-...
The identification of novel pan-sigma receptor (SR) modulators, potentially useful in cancer treatme...
The identification of novel pan-Sigma Receptor (SR) modulators, potentially useful in cancer treatme...
A rapid and straightforward screening protocol of chiral stationary phases (CSPs) in HPLC and SFC re...
The chiral separation of enantiomeric couples of three potential A3 adenosine receptor antagonists: ...
My three-years-project has been focused on two main topics, Sigma Receptors (SRs) and Lithium carbe...
In our recent researches racemic RC-33 was identified as a potent and highly promising sigma1 recept...
The importance of chirality in drug development is unquestionable, with chiral liquid chromatography...
The majority of biomolecules found in living beings are chiral, therefore chiral molecular recogniti...
The enantiomers of four chiral 3-aryl-substituted--butyrolactones, key intermediates for the prepara...
In our recent researches racemic RC-33 was identified as a potent and metabolically stable σ1 recept...
Methoxycarbonyl-1-phenyl-2-cyclopropylmethyl based derivatives cis-(+)-1a [cis-(+)-MR200], cis-(-)-1...
In our recent researches racemic RC-33 was identified as a potent and highly promising \u3c31 recept...
A direct HPLC enantioseparation of three representative compounds of a new family of potential non-p...
The enantiomers of four chiral 3-aryl-substituted-\u3b3-butyrolactones, key intermediates for the pr...
The enantiomers of cis-(+/-)-methyl (1R,2S/1S,2R)-2-[(4-hydroxy-4-phenylpiperidin-1-yl)methyl]-1-(4-...
The identification of novel pan-sigma receptor (SR) modulators, potentially useful in cancer treatme...
The identification of novel pan-Sigma Receptor (SR) modulators, potentially useful in cancer treatme...
A rapid and straightforward screening protocol of chiral stationary phases (CSPs) in HPLC and SFC re...
The chiral separation of enantiomeric couples of three potential A3 adenosine receptor antagonists: ...
My three-years-project has been focused on two main topics, Sigma Receptors (SRs) and Lithium carbe...
In our recent researches racemic RC-33 was identified as a potent and highly promising sigma1 recept...
The importance of chirality in drug development is unquestionable, with chiral liquid chromatography...
The majority of biomolecules found in living beings are chiral, therefore chiral molecular recogniti...
The enantiomers of four chiral 3-aryl-substituted--butyrolactones, key intermediates for the prepara...
In our recent researches racemic RC-33 was identified as a potent and metabolically stable σ1 recept...
Methoxycarbonyl-1-phenyl-2-cyclopropylmethyl based derivatives cis-(+)-1a [cis-(+)-MR200], cis-(-)-1...
In our recent researches racemic RC-33 was identified as a potent and highly promising \u3c31 recept...
A direct HPLC enantioseparation of three representative compounds of a new family of potential non-p...
The enantiomers of four chiral 3-aryl-substituted-\u3b3-butyrolactones, key intermediates for the pr...
The enantiomers of cis-(+/-)-methyl (1R,2S/1S,2R)-2-[(4-hydroxy-4-phenylpiperidin-1-yl)methyl]-1-(4-...